Schonfeld Strategic Advisors’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.69M	Buy	+101,565	New	+$6.45M	0.05%	407
2025 Q2	–	Sell	-175,478	Closed	-$7.05M	–	2133
2025 Q1	$7.05M	Buy	+175,478	New	+$8.06M	0.05%	422
2024 Q3	–	Sell	-15,699	Closed	-$851K	–	2110
2024 Q2	$851K	Sell	15,699 -23,915	-60%	-$1.44M	0.01%	1278
2024 Q1	$2.78M	Buy	39,614 +35,650	+899%	+$2.76M	0.02%	875
2023 Q4	$331K	Sell	3,964 -9,917	-71%	-$359K	﹤0.01%	1401
2023 Q3	$409K	Sell	13,881 -16,936	-55%	-$564K	﹤0.01%	1255
2023 Q2	$1.01M	Buy	30,817 +3,383	+12%	+$125K	0.01%	973
2023 Q1	$965K	Sell	27,434 -29,427	-52%	-$1.2M	0.01%	976
2022 Q4	$2.61M	Buy	+56,861	New	+$2.45M	0.02%	715
2022 Q3	–	Sell	-79,366	Closed	-$3.12M	–	3000
2022 Q2	$3.12M	Buy	79,366 +71,166	+868%	+$2.87M	0.03%	613
2022 Q1	$302K	Sell	8,200 -93,500	-92%	-$3.32M	﹤0.01%	1692
2021 Q4	$4.63M	Buy	101,700 +22,184	+28%	+$856K	0.04%	486
2021 Q3	$2.84M	Buy	79,516 +59,216	+292%	+$1.74M	0.03%	598
2021 Q2	$402K	Buy	+20,300	New	+$477K	﹤0.01%	1302
2020 Q2	–	Sell	-13,263	Closed	-$156K	–	1296
2020 Q1	$156K	Buy	+13,263	New	+$169K	0.01%	952
2016 Q4	–	Sell	-20,000	Closed	-$184K	–	563
2016 Q3	$184K	Buy	+20,000	New	+$209K	0.03%	370